Drug Pipeline

Mecobalamin 5 MG Disintegrating Oral Tablet Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07133438 Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion… Retinal Vein Occlusion (RVO) Recruiting
Phase 3
NCT07423390 Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral… Peripheral Neuropathy Due to Chemotherapy Recruiting
NCT05165069 The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand… Hand-foot Syndrome Active, Not Recruiting
Sponsors Running Mecobalamin 5 MG Disintegrating Oral Tablet Trials
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) First Affiliated Hospital of Chongqing Medical University (1) Qinghai Red Cross Hospital (1)
Get alerts when Mecobalamin 5 MG Disintegrating Oral Tablet trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free